| - GRCh37:
- Chr2:21224901-21224902
- GRCh38:
- Chr2:21002029-21002030
| APOB | K4465fs | Hypercholesterolemia, autosomal dominant, type B | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21225074
- GRCh38:
- Chr2:21002202
| APOB | I4407T | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21225136
- GRCh38:
- Chr2:21002264
| APOB | E4387fs | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21225143
- GRCh38:
- Chr2:21002271
| APOB | L4384P | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21225159
- GRCh38:
- Chr2:21002287
| APOB | Q4379* | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21225164-21225165
- GRCh38:
- Chr2:21002292-21002293
| APOB | I4377fs | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21225180
- GRCh38:
- Chr2:21002308
| APOB | Q4372* | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21225269
- GRCh38:
- Chr2:21002397
| APOB | P4342fs | Hypobetalipoproteinemia | Likely pathogenic (Aug 20, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21225274
- GRCh38:
- Chr2:21002402
| APOB | Y4340* | not specified | Likely pathogenic (Jan 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21225715-21225716
- GRCh38:
- Chr2:21002843-21002844
| APOB | I4194fs | Hypercholesterolemia, autosomal dominant, type B | Likely pathogenic (Feb 1, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21226113
- GRCh38:
- Chr2:21003241
| APOB | E4061fs | Familial hypobetalipoproteinemia | Pathogenic (Aug 1, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr2:21227323
- GRCh38:
- Chr2:21004451
| APOB | | Familial hypobetalipoproteinemia | Pathogenic (Sep 1, 1996) | no assertion criteria provided |
| - GRCh37:
- Chr2:21227523-21227524
- GRCh38:
- Chr2:21004651-21004652
| APOB | D3938fs | Hypobetalipoproteinemia | Likely pathogenic (Jan 19, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21227548
- GRCh38:
- Chr2:21004676
| APOB | | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Likely pathogenic (May 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21227549
- GRCh38:
- Chr2:21004677
| APOB | | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21227976
- GRCh38:
- Chr2:21005104
| APOB | Q3922* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jul 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228208
- GRCh38:
- Chr2:21005336
| APOB | N3845fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Mar 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228275
- GRCh38:
- Chr2:21005403
| APOB | V3822fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jan 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228343
- GRCh38:
- Chr2:21005471
| APOB | K3799fs | Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Oct 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228410
- GRCh38:
- Chr2:21005538
| APOB | S3777* | not provided | Pathogenic (Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21228679-21228680
- GRCh38:
- Chr2:21005807-21005808
| APOB | F3687* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jul 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228680
- GRCh38:
- Chr2:21005808
| APOB | F3687fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21228700
- GRCh38:
- Chr2:21005828
| APOB | Y3680* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B
| Pathogenic/Likely pathogenic (Aug 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21228972
- GRCh38:
- Chr2:21006100
| APOB | E3590K | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21229107
- GRCh38:
- Chr2:21006235
| APOB | E3545* | Familial hypobetalipoproteinemia | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21229160
- GRCh38:
- Chr2:21006288
| APOB | R3527L | Hypercholesterolemia, familial, 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21229413
- GRCh38:
- Chr2:21006541
| APOB | E3443* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Nov 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21229502
- GRCh38:
- Chr2:21006630
| APOB | T3413fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1, Hypobetalipoproteinemia, not provided | Pathogenic/Likely pathogenic (Nov 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21229553
- GRCh38:
- Chr2:21006681
| APOB | A3396D | Hypercholesterolemia, autosomal dominant, type B | Likely pathogenic (Jun 16, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:21229554
- GRCh38:
- Chr2:21006682
| APOB | A3396T | Hypercholesterolemia, autosomal dominant, type B | Likely pathogenic (Oct 19, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr2:21229558
- GRCh38:
- Chr2:21006686
| APOB | K3394N | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21229558
- GRCh38:
- Chr2:21006686
| APOB | K3394N | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, Hypercholesterolemia, familial, 1
| Pathogenic/Likely pathogenic (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21229559
- GRCh38:
- Chr2:21006687
| APOB | K3394T | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21229569
- GRCh38:
- Chr2:21006697
| APOB | R3391fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jun 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21229780
- GRCh38:
- Chr2:21006908
| APOB | F3320fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Dec 28, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230034
- GRCh38:
- Chr2:21007162
| APOB | E3236* | Hypercholesterolemia, autosomal dominant, type B | Likely pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230107-21230108
- GRCh38:
- Chr2:21007235-21007236
| APOB | N3211fs | not provided, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1
| Pathogenic/Likely pathogenic (Mar 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21230125
- GRCh38:
- Chr2:21007253
| APOB | D3205fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Mar 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230217
- GRCh38:
- Chr2:21007345
| APOB | A3175fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1
| Pathogenic (Jun 18, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230419-21230421
- GRCh38:
- Chr2:21007547-21007549
| APOB | N3107del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21230540
- GRCh38:
- Chr2:21007668
| APOB | K3067fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Sep 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230559-21230560
- GRCh38:
- Chr2:21007687-21007688
| APOB | P3061fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Mar 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230585-21230588
- GRCh38:
- Chr2:21007713-21007716
| APOB | N3051fs | Hypercholesterolemia, autosomal dominant, type B | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21230621-21230625
- GRCh38:
- Chr2:21007749-21007753
| APOB | F3039fs | not provided, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1 | Pathogenic/Likely pathogenic (Dec 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21231000-21231001
- GRCh38:
- Chr2:21008128-21008129
| APOB | L2914fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231145-21231146
- GRCh38:
- Chr2:21008273-21008274
| APOB | N2865fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jul 21, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231208-21231209
- GRCh38:
- Chr2:21008336-21008337
| APOB | F2845fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Aug 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231348
- GRCh38:
- Chr2:21008476
| APOB | E2798* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, not provided
| Pathogenic (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21231663-21231664
- GRCh38:
- Chr2:21008791-21008792
| APOB | L2693fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jul 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231771-21231774
- GRCh38:
- Chr2:21008899-21008902
| APOB | F2656fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Nov 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231879
- GRCh38:
- Chr2:21009007
| APOB | | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231889
- GRCh38:
- Chr2:21009017
| APOB | F2617fs | not provided | Likely pathogenic (Apr 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21231954-21231955
- GRCh38:
- Chr2:21009082-21009083
| APOB | T2596fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21232036
- GRCh38:
- Chr2:21009164
| APOB | Y2568* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Oct 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232041
- GRCh38:
- Chr2:21009169
| APOB | Q2567* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Mar 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232135
- GRCh38:
- Chr2:21009263
| APOB | Y2535* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Dec 7, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232182
- GRCh38:
- Chr2:21009310
| APOB | R2520* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232203
- GRCh38:
- Chr2:21009331
| APOB | R2513* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21232251
- GRCh38:
- Chr2:21009379
| APOB | Q2497* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jul 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232337
- GRCh38:
- Chr2:21009465
| APOB | L2468fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jul 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232591-21232592
- GRCh38:
- Chr2:21009719-21009720
| APOB | Q2383fs | Hypercholesterolemia, familial, 1 | Likely pathogenic (Sep 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21232905
- GRCh38:
- Chr2:21010033
| APOB | Q2279* | Familial hypobetalipoproteinemia 1 | Pathogenic (Jul 1, 2005) | no assertion criteria provided |
| - GRCh37:
- Chr2:21232941
- GRCh38:
- Chr2:21010069
| APOB | Q2267* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (May 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233066-21233067
- GRCh38:
- Chr2:21010194-21010195
| APOB | T2225fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Oct 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233173
- GRCh38:
- Chr2:21010301
| APOB | Y2189* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233197
- GRCh38:
- Chr2:21010325
| APOB | F2181fs | not provided, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1
| Pathogenic/Likely pathogenic (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21233200
- GRCh38:
- Chr2:21010328
| APOB | Q2180fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233337
- GRCh38:
- Chr2:21010465
| APOB | V2135fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Jun 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233410
- GRCh38:
- Chr2:21010538
| APOB | K2110fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21233559
- GRCh38:
- Chr2:21010687
| APOB | D2061Y | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21233847
- GRCh38:
- Chr2:21010975
| APOB | E1965* | Familial hypobetalipoproteinemia 1 | Likely pathogenic (Jul 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21234131-21234132
- GRCh38:
- Chr2:21011259-21011260
| APOB | T1870fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21234133-21234134
- GRCh38:
- Chr2:21011261-21011262
| APOB | N1869fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21234224
- GRCh38:
- Chr2:21011352
| APOB | I1839T | Familial hypercholesterolemia | Likely pathogenic (Jan 18, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:21234277
- GRCh38:
- Chr2:21011405
| APOB | H1822fs | Familial hypobetalipoproteinemia | Pathogenic (Sep 12, 1988) | no assertion criteria provided |
| - GRCh37:
- Chr2:21234474-21234477
- GRCh38:
- Chr2:21011602-21011605
| APOB | N1755fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Nov 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21234502
- GRCh38:
- Chr2:21011630
| APOB | Y1746* | Familial hypobetalipoproteinemia | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21234623-21234624
- GRCh38:
- Chr2:21011751-21011752
| APOB | T1706fs | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1
| Pathogenic (Jul 31, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21234749
- GRCh38:
- Chr2:21011877
| APOB | L1664fs | not provided | Pathogenic (Dec 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21235089
- GRCh38:
- Chr2:21012217
| APOB | Q1551* | Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:21235150
- GRCh38:
- Chr2:21012278
| APOB | N1531fs | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21235169
- GRCh38:
- Chr2:21012297
| APOB | S1524F | Familial hypobetalipoproteinemia 1 | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:21235269
- GRCh38:
- Chr2:21012397
| APOB | R1491* | not provided | Likely pathogenic (May 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21235311
- GRCh38:
- Chr2:21012439
| APOB | Q1477* | Familial hypobetalipoproteinemia | Pathogenic (Apr 14, 1992) | no assertion criteria provided |
| - GRCh37:
- Chr2:21235388
- GRCh38:
- Chr2:21012516
| APOB | G1451fs | Familial hypobetalipoproteinemia | Pathogenic (Mar 1, 1990) | no assertion criteria provided |
| - GRCh37:
- Chr2:21236159
- GRCh38:
- Chr2:21013287
| APOB | Y1363* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1
| Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21236159
- GRCh38:
- Chr2:21013287
| APOB | Y1363* | Familial hypobetalipoproteinemia | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21236251
- GRCh38:
- Chr2:21013379
| APOB | R1333* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Nov 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21237384
- GRCh38:
- Chr2:21014512
| APOB | E1260* | Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Oct 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238016-21238027
- GRCh38:
- Chr2:21015144-21015155
| APOB | | Familial hypobetalipoproteinemia | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:21238041
- GRCh38:
- Chr2:21015169
| APOB | Y1200* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238079
- GRCh38:
- Chr2:21015207
| APOB | K1188* | Hypercholesterolemia, autosomal dominant, type B | Pathogenic (Jun 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238130
- GRCh38:
- Chr2:21015258
| APOB | E1171* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238241
- GRCh38:
- Chr2:21015369
| APOB | | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Likely pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238241
- GRCh38:
- Chr2:21015369
| APOB | | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Likely pathogenic (Oct 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21238405-21238408
- GRCh38:
- Chr2:21015533-21015536
| APOB | E1116fs | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21241973
- GRCh38:
- Chr2:21019101
| APOB | E1004fs | Hypercholesterolemia, familial, 1 | Pathogenic (Mar 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21242594
- GRCh38:
- Chr2:21019722
| APOB | | not provided | Likely pathogenic (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21242600-21242606
- GRCh38:
- Chr2:21019728-21019734
| APOB | G997fs | Hypobetalipoproteinemia | Likely pathogenic (Jun 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:21242615
- GRCh38:
- Chr2:21019743
| APOB | Y993* | Hypercholesterolemia, autosomal dominant, type B, Familial hypobetalipoproteinemia 1 | Pathogenic (May 13, 2021) | criteria provided, single submitter |